SCHEMBL1124562

SCHEMBL1124562

O=C(C=Cc1ccc(C(F)(F)F)cc1)NCc1ccc(-c2ncccn2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
HDAC1 Q13547 7/20 0.51
HDAC3 O15379 6/20 0.51
HDAC2 Q92769 6/20 0.51
HDAC10 Q969S8 3/20 0.51
HDAC11 Q96DB2 3/20 0.51
HDAC8 Q9BY41 3/20 0.51
HDAC6 Q9UBN7 3/20 0.51
HDAC5 Q9UQL6 3/20 0.51
ADAM17 P78536 1/20 0.51
MMP1 P03956 2/20 0.50
MMP2 P08253 2/20 0.50
MMP9 P14780 2/20 0.50
HDAC4 P56524 2/20 0.50
HDAC7 Q8WUI4 2/20 0.50
HDAC9 Q9UKV0 2/20 0.50
POLB P06746 1/20 0.50
NCOR2 Q9Y618 2/20 0.48
KDM1A O60341 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2334536 0.88 HDAC1 (0.53) KDM4ESMN1; SMN2HDAC1HDAC3HDAC2
SCHEMBL1124162 0.88 HDAC1 (0.53) KDM4ESMN1; SMN2HDAC1HDAC3HDAC2
SCHEMBL1124180 0.87 KDM4E (0.62) KDM4ESMN1; SMN2HDAC1HDAC3HDAC2
SCHEMBL13857234 0.83 MMP1 (0.73) HDAC1HDAC3HDAC2HDAC10HDAC11
SCHEMBL1124352 0.82 POLB (0.53) KDM4ESMN1; SMN2HDAC1HDAC3HDAC2
SCHEMBL1124535 0.81 TP53 (0.52) KDM4ESMN1; SMN2HDAC1HDAC3HDAC2
SCHEMBL1124356 0.78 HDAC3 (0.50) KDM4ESMN1; SMN2HDAC1HDAC3HDAC2
SCHEMBL2374022 0.75 NAMPT (0.50) KDM4ESMN1; SMN2HDAC1HDAC3HDAC2
SCHEMBL1124141 0.75 NAMPT (0.50) KDM4ESMN1; SMN2HDAC1HDAC3HDAC2
SCHEMBL13857128 0.75 MMP1 (0.73) KDM4EHDAC1HDAC3HDAC2MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282996-A1 TETRAHYDROISOQUINOLINES AS ANTIMALARIAL AGENTS Actelion Pharmaceuticals Ltd. (CH) 2011-02-16 EP claimed